{"member_organisations": "IPEC Europe is member of IPEC Federation (ipec.org) and of EXCiPACT (excipact.org)", "identification_number": "341962119314-36", "fields_of_interest": "Trade, Consumers, Public Health", "head_office_address": "Rue du Luxembourg 16B", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "Carole Capitaine", "industry_forums": "", "grants": "", "country_code": "be", "inter_groups": "", "eu_initiatives": "Directive 2011/62/EU of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products \n \nEuropean Commission Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use (OJ 2015/C 95/02)", "level_of_interest": "European", "organisation_name": "International Pharmaceutical Excipients Council Europe (IPEC Europe)", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "Carole Capitaine", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "4.3677494", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "26/10/2015", "estimate_of_costs_absolute_amount": "", "website_address": "http://ipec-europe.org", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Brussels", "membership": "The complete list of IPEC Europe members can be found on the website: http://ipec-europe.org/members.asp", "head_office_post_code": "1000", "position": "Executive Manager", "financial_year_start_date": "01/01/2017", "head_office_country": "Belgium", "number_of_ep_accredited_persons": "", "relevant_communication": "IPEC Federation Position Statement on EU Guidelines on Risk Assessment for Excipients \n(http://ipec-europe.org/newsdetail.asp?nid=34) \n \nIPEC Europe Task Force acts to help industry meet EU risk assessment guidelines for excipients \n(http://ipec-europe.org/newsdetail.asp?nid=35)", "financial_year_end_date": "01/12/2017", "lat": "50.8403481", "estimate_of_costs_as_a_range": "0-9999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "ASBL", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "1. To be the primary voice of European producers, suppliers and users of pharmaceutical excipients. \n \n2. To develop, implement and promote voluntary, harmonised guidance for the pharmaceutical industry which is designed to ensure that excipients used in finished drug products meet the appropriate standards for quality, safety and functionality. \n \n3. To assist, educate, and cooperate with other industry organizations and scientific bodies working to advance public health on matters relating to the manufacture, use and functionality of excipients. \n \n4. To provide real-time information on excipient legislation via, for example, the IPEC Europe website (http://www.ipec-europe.org) and the newsletter \u2018Excipients Insight\u2019.", "belgium_office_city": "", "head_office_phone": "(+32)22137440"}